LILLY GEMZAR SELLS $31.6 MIL. IN SIX MONTHS ON U.S. MARKET; PRINIVIL IS MERCK's "ACE" IN HOLE WITH 33% U.S. SALES JUMP; FOSAMAX SALES IN EXCESS OF $200 MIL. IN U.S.
Executive Summary
Lilly's Gemzar generated $31.6 mil. in U.S. sales from its May launch for treatment of prostate cancer. Gemzar contributed worldwide sales of $61.9 mil. for 1996, of which $26.3 mil. was in the fourth quarter.